Depo provera use by Indian Health Service
Executive Summary
Will be subject of Aug. 6 hearing before House Interior/Oversight & Investigations Subcommittee. Among the witnesses expected to discuss administration of the unapproved injectible contraceptive by the Indian Health Service (IHS) will be representatives of the IHS and FDA.